Tel Aviv/Zurich, 13 March 2014 – SHL Telemedicine Ltd. (SIX Swiss Exchange:
SHLTN), a leading provider and developer of advanced personal telemedicine solutions,
announced that it has a Japanese PMDA Pre-Market Certification for marketing the
smartheart in Japan. The smartheartTM has received already a marketing approval in
Europe according to the EU Medical Directive (the CE) and the US according to the
American Food and Drug Administration (the FDA).
for more information click here
for more information click here
